ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756169 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756169; 2) Community: the network communities that were significantly associated with the response to NSC 756169; 3) Molecule: the relationships between components within communities and NSC 756169; 4) MDR: the compounds that were significantly associated with the NSC 756169.

NSC Compound Enrichment Correlation
NSC 11668 N4,N6-bis(3-chlorophenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine 0.0112425217758227 0.26313837
NSC 172599 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- 0.0112425217758227 0.1624161
NSC 175630 Toyocamycin, 6-amino- 0.0112425217758227 0.31223985
NSC 212446 Null 0.0112425217758227 0.39013037
NSC 302289 BOHLMANN K2631 0.0112425217758227 0.062490109
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.0112425217758227 0.48337633
NSC 328403 Acetamide, N-(4-formyl-5,6,7,9-tetrahydro-1,2,3,10- tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0112425217758227 0.60980653
NSC 3424 Acridine, 9-(4-[bis(2-chloroethyl)amino]-1-methylbutylamino)-6-chloro-2-methoxy-, dihydrochloride 0.0112425217758227 0.34036288
NSC 372950 Null 0.0112425217758227 0.3798561
NSC 381866 BAFILOMYCIN DERIV. 0.0112425217758227 0.5064057
Total:133  Current:45    [First] [Prev] [Next] [Last]